Two sites of action for PLD2 inhibitors: The enzyme catalytic center and an allosteric, phosphoinositide biding pocket

PLD2 inhibition by small-molecule compound NFOT is due to its binding to the natural site used by PLD-activator PIP2 in addition to the catalytic site. Also shown is another PLD inhibitor (FIPI) as binding to the PLD catalytic center.222